PrognomiQ is based in San Mateo, CA. It has raised $34M in total funding. Latest round: Series C.
PrognomiQ funding overview
PrognomiQ is based in San Mateo, CA. PrognomiQ has raised $34M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series C announced in November 2024. The round record for PrognomiQ runs through 2024; nothing later has been disclosed. Investors on record include aMoon, Bruker Corporation, Fidelity Management and Research Company LLC, T. Rowe Price Associates, Inc., Invus, Maverick Ventures and 2 others. 8 distinct backers are named across the disclosed rounds.
PrognomiQ at a glance
Total raised
$34M
Latest round
Series C
Latest round date
November 2024
Headquarters
San Mateo, CA
Notable investors
aMoon, Bruker Corporation, Fidelity Management and Research Company LLC, T. Rowe Price Associates, Inc., Invus, Maverick Ventures, Emerson Collective, Wing VC
Frequently asked about PrognomiQ funding
How much has PrognomiQ raised?
PrognomiQ has raised $34M in total disclosed funding across the rounds on record.
Who has invested in PrognomiQ?
aMoon, Bruker Corporation, Fidelity Management and Research Company LLC, T. Rowe Price Associates, Inc., Invus, Maverick Ventures are named among the investors backing PrognomiQ.
What was the latest PrognomiQ funding round?
The most recent disclosed round is a Series C, announced in November 2024.
Where is PrognomiQ based?
PrognomiQ is based in San Mateo, CA.
When did PrognomiQ last raise?
The last disclosed PrognomiQ round closed in November 2024 at Series C.
Totals shown for PrognomiQ aggregate every disclosed round on file. To see how that compares, browse the companies in San Mateo and the investors behind them below.
